Silke Baasner
11Patents
4h-index
24Co-inventors
60Inventor score
Filing activity: Nov 8, 1996 → Oct 5, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8148546B2 | Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors | Human Necessities | 54 | Active |
| US6706722B2 | Heteroaryl derivatives and their use as medicaments | Human Necessities | 34 | Expired |
| US10272102B2 | Hydroxyalkyl starch for the treatment of hematological neoplasms | Human Necessities | 6 | Active |
| US7205299B2 | Indole derivatives having an apoptosis-inducing effect | Chemistry; Metallurgy | 5 | Expired |
| US7211588B2 | N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation | Chemistry; Metallurgy | 3 | Expired |
| US5837462A | Tumorigenic cell lines altered by genetic engineering and their use for the testing of antitumor drugs | Chemistry; Metallurgy | 1 | Expired |
| US8067456B2 | Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs) | Chemistry; Metallurgy | 1 | Active |
| US7375127B2 | Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) | Chemistry; Metallurgy | 0 | Active |
| US10202634B2 | Detection of starch levels in biological matrices | Physics | 0 | Active |
| US8541462B2 | Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors | Human Necessities | 0 | Active |
| US11406614B2 | Composition comprising EPA and DHA for an enhanced efficacy of anticancer agents | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.